Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
76 participants
Study Classification
INTERVENTIONAL
Study Start Date
2023-08-01
Study Completion Date
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to clinically evaluate the performance of GIOMER based resin composite restorations versus conventional nanohybrid resin composite restorations in complex proximal carious cavities in posterior teeth over 2 years follow up. The null hypothesis will be proposed that there will be no difference in the clinical performance of GIOMER based resin composite restorations versus conventional nanohybrid resin composite restorations in complex proximal carious cavities in posterior teeth over 2 years follow up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite
NCT05949502
Caries Class II
NOT_YET_RECRUITING
NA
Partial Caries Removal in Permanent Molars Restored Using Giomer
NCT06601972
Caries, Dental
NOT_YET_RECRUITING
NA
Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).
NCT05403008
Dental Caries
UNKNOWN
NA
Contact Tightness of Zirconomer Versus Nanohybrid Composite in Occlusoproximal Cavities in Molars
NCT06596707
Contact Tightness in Restoring Proximal Surfaces in Posterior Teeth
ACTIVE_NOT_RECRUITING
NA
Evaluation of Low-shrinkage Giomer Versus Resin-Modified Glass Ionomer in Cervical Caries Lesions: A Clinical Trial
NCT05930548
Caries, Cervical
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Scientific background:
One of the advancements in resin composite technology to support its use as a bioactive material, is the evolution of GIOMER based resin composite material which has an added benefit of sustained fluoride and other ions release and rechargeability. A distinguishing feature of the "giomer" class of restorative materials is the stable surface prereacted glass core (sPRG) that is lined with an ionomer in a resin matrix. This configuration enables the glass core to be protected from moisture, giving it long term aesthetics and the durability of conventional resin composites with ion release and recharge1. When evaluating the clinical performance of low shrinkage giomer based resin composite (Beautifil II LS; Shofu Inc.) compared with a conventional nanohybrid resin composite in class I and class II cavities, It was found that in both groups, according to FDI criteria, the restorations were mostly rated with best scores (Score 1 or 2) regarding the biological, functional, and optical parameters 2. Also, after five years of clinical performance, both the nano-hybrid giomer restorative materials flowable giomer (Beautifil Flow Plus F00; Shofu Inc.) and the conventional nano-hybrid giomer restorative material (Beautifil II; Shofu Inc.) were comparably acceptable and not significantly different for any of the parameters evaluated in occlusal cavities 3. Meanwhile in a recent systematic review, it was concluded that GIOMER based resin composites showed similar clinical performance concerning marginal adaptation and better surface roughness when compared to Resin-modified glass ionomer cement 4.
Statement of the problem:
The survival rate for resin-based composite restorations declined to roughly 85-90% after ten years. Bulk fractures and wear, which accounted for about 70% of replacements, were the main causes of restorative replacement. About 20% of the resin-based restorations were replaced because of caries at the margins of the restorations, and 10% were due to retention loss, poor color matching, poor marginal integrity, endodontic therapy, or cusp fracture 5. These failures are correlated mainly with patient risk profile i.e., caries risk , presence of parafunctional habits and those with high number of restored surfaces (complex cavities) 6.
Rationale:
In a retrospective study7, the percentage of clinically satisfactory complex Class II resin composite was 78% after five years. The main reasons for the failure presented were related to the fracture of the restoration (Bravo-16%) and defective marginal adaptation (Charlie-8.2%). Although many studies have evaluated the clinical performance of GIOMER based resin composite 2-4, none of them evaluated its clinical performance in complex Class II cavities, up till now, where the restorations are subjected to high stress conditions.
External validity:
Offering the patient, a bioactive giomer based restoration with an added benefit of sustained remineralizing fluoride and other ions release also rechargeability while on the same time it has the long term aesthetics and clinical longevity of conventional resin composite restorations.
Choice of the comparator:
A conventional nanohybrid resin composite material will be used as the comparator as it gives an accepted long term clinical performance according to a recent systematic review 7. Aim of the study:
The aim of the study is to clinically evaluate the performance of GIOMER based resin composite restorations versus conventional nanohybrid resin composite restorations in complex proximal carious cavities in posterior teeth over 2 years follow up.
Methods:
Study Settings:
This clinical trial will be held in Conservative dentistry department clinic, Faculty of Dentistry- Cairo University, Egypt.
Sample size Calculation:
The sample size was calculated based on a previous study by Torres et al in 2020, in which percentage of clinically excellent large class 2 restorations regarding fracture and retention was 87.5%. By implementing a two tailed Z test for difference between two independent proportions with an alpha level of 5% and a power of 80%. The minimum sample size needed was 34 per group in order to detect a difference of 30%. Sample size was increased by 10% to compensate for possible dropouts to reach 38 teeth per group. Sample size was performed using G\*Power version 3.1.9.2 for windows.
Methods: Assignment of interventions
Allocation:
Sequence generation:
Simple randomization will be made by a contributor, who will not be further involved in any of the phases of the clinical trial, to generate random numbers using Random Sequence Generator, Randomness and Integrity Services Ltd (https://www.random.org/).
Allocation concealment:
The operator will choose between random numbers placed in an opaque sealed envelope.
Blinding:
The participants and both assessors will be blinded to the type of the material used and the application technique.
Interventions:
After profound local anesthesia, conservative cavity preparations will be performed with highspeed burs under constant cooling. The cavity outline and carious tissue will be removed following the recent conservative cavity preparation and caries excavation guidelines. All restored teeth will be isolated using a rubber dam. After applying the suitable matrix system and wooden wedge.
Intervention group:
Selective enamel etching with 37% phosphoric acid for 30 second will be done then the bonding agent (BeautiBond Universal, Shofu, Inc., Japan) will be applied following the manufacturer's instructions. The restorative material (Beautifil II, Shofu, Inc., Japan ) will be inserted into the cavity which is converted into a class I configuration using a centripetal build-up sequence and light cured following the manufacturer's instructions, then finished and polished after occlusion adjustment.
Comparator group:
The universal bonding agent ( Prime and Bond Active, Dentsply Sirona ) will be applied following the manufacturer's instructions with previous selective enamel etching with 37% phosphoric acid for 30 seconds. The restorative material (Neo Spectra, Dentsply Sirona) will be inserted into the cavity as mentioned before and light cured following the manufacturer's instructions, then finished and polished after occlusion adjustment.
Data collection methods:
\*Baseline data collection: For every patient medical and dental history will be obtained. All patients will be given oral hygiene instructions before operative treatment, and they will be referred to the periodontology department for scaling and polishing prior restorative procedures if needed.
\*Outcome data collection: FDI criteria for clinical evaluation of dental restoration will be used by the two assessors. If they differ in the evaluation score, they will discuss together till reaching a consensus.
Patient retention:
The patients' phone number will be recorded in their charts. Before the follow up visit, the patient will receive a reminder phone call by If the patient did not answer, another appointment will be scheduled within a week.
Data management:
All data of the trial will be stored on a computer and encrypted using a password. Data will be backed up on cloud storage to prevent it from being lost.
Statistical methods:
Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 25 (SPSS Inc., Chicago, IL). Numerical data will be represented as mean and standard deviation or median and range. Categorical data will be represented as numbers and percentages. Data will be explored for normality using Kolmogrov-Smirnov test and Shapiro-Wilk test. Comparisons between two groups for normally distributed numeric variables will be done using the Student's t-test while for non normally distributed numeric variables will be done by Mann-Whitney test. Comparisons between categorical variables will be performed using the chi square test. An equivalence limit will be tested. A p-value less than or equal to 0.05 will be considered statistically significant. All tests will be two tailed.
Harms:
The operator would inform the participants about any possible harm (post-operative hypersensitivity or fracture of the restoration). If present, participants are instructed to contact the operator immediately by a phone call.
Research ethics approval Application forms for conducting clinical trials, checklist and informed consent of the Research Ethics Committee (REC) Faculty of Dentistry, Cairo University will be fulfilled, this is to prevent any unethical management or harms during the study toward the participants. The operator will be responsible for obtaining the informed consents from the participants during the enrollment day.
Protocol amendments If a new protocol will be used a protocol amendment will be registered with a copy of the new protocol and an explanation about the reasons for it. If there is a change in this protocol that affects trial ethics or the scientific content of the trial, an amendment with brief explanation will be also submitted.
Confidentiality The personal data of the participants will not present on the protocol form and it would be secured for 10 years after the trial to protect their privacy.
Declaration of interests There is no conflict of interest. Funding is accepted from Shofu, Inc., Japan and Ivoclar Vivadent, Schaan, Liechtenstein.
Ancillary and post-trial care Patients will be followed up after the restorative work to maintain the oral hygiene measures. When there is any evidence of restoration failure, patients will be treated by immediate restoration replacement by different restorative option to the tooth.
Dissemination policy Full protocol will be published online in www.clinicaltrials.gov to keep the integrity of the research methods and to avoid repetition. The results of this clinical trial will be internationally published.
Declaration of originality:
This research has not been submitted to any other universities, institutions or even persons for the award of any degree, diploma, or publication any time before.
One of the advancements in resin composite technology to support its use as a bioactive material, is the evolution of GIOMER based resin composite material which has an added benefit of sustained fluoride and other ions release and rechargeability. A distinguishing feature of the "giomer" class of restorative materials is the stable surface prereacted glass core (sPRG) that is lined with an ionomer in a resin matrix. This configuration enables the glass core to be protected from moisture, giving it long term aesthetics and the durability of conventional resin composites with ion release and recharge1. When evaluating the clinical performance of low shrinkage giomer based resin composite (Beautifil II LS; Shofu Inc.) compared with a conventional nanohybrid resin composite in class I and class II cavities, It was found that in both groups, according to FDI criteria, the restorations were mostly rated with best scores (Score 1 or 2) regarding the biological, functional, and optical parameters 2. Also, after five years of clinical performance, both the nano-hybrid giomer restorative materials flowable giomer (Beautifil Flow Plus F00; Shofu Inc.) and the conventional nano-hybrid giomer restorative material (Beautifil II; Shofu Inc.) were comparably acceptable and not significantly different for any of the parameters evaluated in occlusal cavities 3. Meanwhile in a recent systematic review, it was concluded that GIOMER based resin composites showed similar clinical performance concerning marginal adaptation and better surface roughness when compared to Resin-modified glass ionomer cement 4.
Statement of the problem:
The survival rate for resin-based composite restorations declined to roughly 85-90% after ten years. Bulk fractures and wear, which accounted for about 70% of replacements, were the main causes of restorative replacement. About 20% of the resin-based restorations were replaced because of caries at the margins of the restorations, and 10% were due to retention loss, poor color matching, poor marginal integrity, endodontic therapy, or cusp fracture 5. These failures are correlated mainly with patient risk profile i.e., caries risk , presence of parafunctional habits and those with high number of restored surfaces (complex cavities) 6.
Rationale:
In a retrospective study7, the percentage of clinically satisfactory complex Class II resin composite was 78% after five years. The main reasons for the failure presented were related to the fracture of the restoration (Bravo-16%) and defective marginal adaptation (Charlie-8.2%). Although many studies have evaluated the clinical performance of GIOMER based resin composite 2-4, none of them evaluated its clinical performance in complex Class II cavities, up till now, where the restorations are subjected to high stress conditions.
External validity:
Offering the patient, a bioactive giomer based restoration with an added benefit of sustained remineralizing fluoride and other ions release also rechargeability while on the same time it has the long term aesthetics and clinical longevity of conventional resin composite restorations.
Choice of the comparator:
A conventional nanohybrid resin composite material will be used as the comparator as it gives an accepted long term clinical performance according to a recent systematic review 7. Aim of the study:
The aim of the study is to clinically evaluate the performance of GIOMER based resin composite restorations versus conventional nanohybrid resin composite restorations in complex proximal carious cavities in posterior teeth over 2 years follow up.
Methods:
Study Settings:
This clinical trial will be held in Conservative dentistry department clinic, Faculty of Dentistry- Cairo University, Egypt.
Sample size Calculation:
The sample size was calculated based on a previous study by Torres et al in 2020, in which percentage of clinically excellent large class 2 restorations regarding fracture and retention was 87.5%. By implementing a two tailed Z test for difference between two independent proportions with an alpha level of 5% and a power of 80%. The minimum sample size needed was 34 per group in order to detect a difference of 30%. Sample size was increased by 10% to compensate for possible dropouts to reach 38 teeth per group. Sample size was performed using G\*Power version 3.1.9.2 for windows.
Methods: Assignment of interventions
Allocation:
Sequence generation:
Simple randomization will be made by a contributor, who will not be further involved in any of the phases of the clinical trial, to generate random numbers using Random Sequence Generator, Randomness and Integrity Services Ltd (https://www.random.org/).
Allocation concealment:
The operator will choose between random numbers placed in an opaque sealed envelope.
Blinding:
The participants and both assessors will be blinded to the type of the material used and the application technique.
Interventions:
After profound local anesthesia, conservative cavity preparations will be performed with highspeed burs under constant cooling. The cavity outline and carious tissue will be removed following the recent conservative cavity preparation and caries excavation guidelines. All restored teeth will be isolated using a rubber dam. After applying the suitable matrix system and wooden wedge.
Intervention group:
Selective enamel etching with 37% phosphoric acid for 30 second will be done then the bonding agent (BeautiBond Universal, Shofu, Inc., Japan) will be applied following the manufacturer's instructions. The restorative material (Beautifil II, Shofu, Inc., Japan ) will be inserted into the cavity which is converted into a class I configuration using a centripetal build-up sequence and light cured following the manufacturer's instructions, then finished and polished after occlusion adjustment.
Comparator group:
The universal bonding agent ( Prime and Bond Active, Dentsply Sirona ) will be applied following the manufacturer's instructions with previous selective enamel etching with 37% phosphoric acid for 30 seconds. The restorative material (Neo Spectra, Dentsply Sirona) will be inserted into the cavity as mentioned before and light cured following the manufacturer's instructions, then finished and polished after occlusion adjustment.
Data collection methods:
\*Baseline data collection: For every patient medical and dental history will be obtained. All patients will be given oral hygiene instructions before operative treatment, and they will be referred to the periodontology department for scaling and polishing prior restorative procedures if needed.
\*Outcome data collection: FDI criteria for clinical evaluation of dental restoration will be used by the two assessors. If they differ in the evaluation score, they will discuss together till reaching a consensus.
Patient retention:
The patients' phone number will be recorded in their charts. Before the follow up visit, the patient will receive a reminder phone call by If the patient did not answer, another appointment will be scheduled within a week.
Data management:
All data of the trial will be stored on a computer and encrypted using a password. Data will be backed up on cloud storage to prevent it from being lost.
Statistical methods:
Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 25 (SPSS Inc., Chicago, IL). Numerical data will be represented as mean and standard deviation or median and range. Categorical data will be represented as numbers and percentages. Data will be explored for normality using Kolmogrov-Smirnov test and Shapiro-Wilk test. Comparisons between two groups for normally distributed numeric variables will be done using the Student's t-test while for non normally distributed numeric variables will be done by Mann-Whitney test. Comparisons between categorical variables will be performed using the chi square test. An equivalence limit will be tested. A p-value less than or equal to 0.05 will be considered statistically significant. All tests will be two tailed.
Harms:
The operator would inform the participants about any possible harm (post-operative hypersensitivity or fracture of the restoration). If present, participants are instructed to contact the operator immediately by a phone call.
Research ethics approval Application forms for conducting clinical trials, checklist and informed consent of the Research Ethics Committee (REC) Faculty of Dentistry, Cairo University will be fulfilled, this is to prevent any unethical management or harms during the study toward the participants. The operator will be responsible for obtaining the informed consents from the participants during the enrollment day.
Protocol amendments If a new protocol will be used a protocol amendment will be registered with a copy of the new protocol and an explanation about the reasons for it. If there is a change in this protocol that affects trial ethics or the scientific content of the trial, an amendment with brief explanation will be also submitted.
Confidentiality The personal data of the participants will not present on the protocol form and it would be secured for 10 years after the trial to protect their privacy.
Declaration of interests There is no conflict of interest. Funding is accepted from Shofu, Inc., Japan and Ivoclar Vivadent, Schaan, Liechtenstein.
Ancillary and post-trial care Patients will be followed up after the restorative work to maintain the oral hygiene measures. When there is any evidence of restoration failure, patients will be treated by immediate restoration replacement by different restorative option to the tooth.
Dissemination policy Full protocol will be published online in www.clinicaltrials.gov to keep the integrity of the research methods and to avoid repetition. The results of this clinical trial will be internationally published.
Declaration of originality:
This research has not been submitted to any other universities, institutions or even persons for the award of any degree, diploma, or publication any time before.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Dental Caries
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Randomized Parallel Controlled Trial. Trial type: Two, Parallel arm design. Trial framework: Equivalence frame Allocation ratio: 1:1.
Primary Study Purpose
TREATMENT
Blinding Strategy
DOUBLE
Investigators
Outcome Assessors
Triple (Investigator, Outcomes Assessor)
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beautifil II Resin composite
Giomer restorative
Group Type
EXPERIMENTAL
complex proximal carious cavities in posterior teeth.
Intervention Type
PROCEDURE
Selective enamel etching with 37% phosphoric acid for 30 second will be done then the bonding agent will be applied following the manufacturer's instructions.
Neo Spectra resin composite
Nano-hybrid resin composite
Group Type
ACTIVE_COMPARATOR
complex proximal carious cavities in posterior teeth.
Intervention Type
PROCEDURE
Selective enamel etching with 37% phosphoric acid for 30 second will be done then the bonding agent will be applied following the manufacturer's instructions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
complex proximal carious cavities in posterior teeth.
Selective enamel etching with 37% phosphoric acid for 30 second will be done then the bonding agent will be applied following the manufacturer's instructions.
Intervention Type
PROCEDURE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients with proximal carious cavities in molars.
2. 18 - 50 years.
3. Males or Females.
4. Good oral hygiene.
5. Co-operative patients approving to participate in the study.
1. Pulp asymptomatic vital carious complex class II upper or lower posterior teeth.
2. The presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.
\-
2. 18 - 50 years.
3. Males or Females.
4. Good oral hygiene.
5. Co-operative patients approving to participate in the study.
1. Pulp asymptomatic vital carious complex class II upper or lower posterior teeth.
2. The presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.
\-
Exclusion Criteria
Poor oral hygiene. Severe medical complications. Pregnancy. Allergic history concerning methacrylates Heavy smoking. Xerostomia. Lack of compliance. Evidence of parafunctional habits Temporomandibular joint disorders.
Teeth involving more than three surfaces and indicated for indirect restorations.
Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis. Severe periodontal problems.
Teeth involving more than three surfaces and indicated for indirect restorations.
Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis. Severe periodontal problems.
Minimum Eligible Age
18 Years
Maximum Eligible Age
55 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rawda Hesham Abd ElAziz
Lecturer, Conservative dentistry department, Faculty of Dentistry
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rawda Hesham Abd ElAziz, Phd
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed Mohamed sabry Mohamed
Cairo, Nasr City, Egypt
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
Egypt
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cons2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial
NCT06950762
NOT_YET_RECRUITING
NA
Clinical Evaluation of Different Bioactive Restorative Materials for Cervical Carious in High Caries Risk Patients
NCT06736964
ENROLLING_BY_INVITATION
NA
Clinical Performance of Injectable Universal Flowable Composite in Proximal Cavities of Posterior Teeth.
NCT05263089
COMPLETED
NA
Clinical Assessment of Indirect Restoration Fabricated From Nano Hybrid Composite Blocks Versus Ceramic Blocks in Badly Broken Teeth One Year Follow up
NCT04563624
UNKNOWN
PHASE1
Clinical Performance Of Conserved Chalky White Demineralized Enamel Cavity Margins Versus Totally Removed Carious Margins In Class V Cavities Restored With Composite Resin
NCT05614076
UNKNOWN
NA
Clinical Performance of Nano Fiber Reinforced Versus Conventional Nano Hybrid Composite in Restoring Premolars
NCT05808075
UNKNOWN
NA
Clinical Performance of Two Fiber Reinforced Resin Composites Versus Nanohybrid Resin Composite in Posterior Teeth Will be Evaluated Using Modified USPHS Criteria
NCT05380973
COMPLETED
NA
Effect of Modeling Resin on Anterior Direct Composite Veneer
NCT06485024
NOT_YET_RECRUITING
NA
Clinical Performance of Short Fiber Reinforced Flowable Resin Composite Restorations 2y RCT
NCT04720638
UNKNOWN
NA
Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients
NCT02856932
UNKNOWN
NA
Injectable Resin Composite Versus Dual-cured Resin Cement for Cementation of Indirect Onlay Restorations
NCT05954156
COMPLETED
NA
Clinical Performance of Fiber Reinforced Composite Versus Microhybrid Composite Restorations
NCT03515265
COMPLETED
NA
Clinical Evaluation of Self- Cure Bulk-Fill Resin Composite Versus Conventional Bulk-Fill Resin Composite Versus Conventional Bulk-Fill Resin Composite Clinical Evaluation of Self- Cure Bulk-Fill Resin Composite Versus Conventional Bulk-Fill Resin Composite
NCT06859086
NOT_YET_RECRUITING
NA
Bioactive Versus Non-Bioactive Restorative System in Deep Carious Molars
NCT06348953
RECRUITING
NA
Clinical Evaluation of Giomer Based Varnish Versus CPP-ACP Varnish in the Management of Dentin Hypersensitivity: a Randomized Clinical Trial
NCT06154941
RECRUITING
NA
Clinical Assessment of Injectable Composite Versus Packable Composite in Treatment of Carious Primary Anterior Teeth
NCT06991582
NOT_YET_RECRUITING
PHASE2
Clinical Evaluation of Fiber Reinforced Resin Composite Base Versus Incremental Packing of Nanohybrid Resin Composite
NCT04019145
COMPLETED
EARLY_PHASE1
Clinical Performance of Two Different Resin-Matrix Ceramic Restorations
NCT07265609
COMPLETED
NA
Clinical Performance of Bioactive Restorative Material Versus Glass Hybrid Restorative in Posterior Restorations
NCT03608306
UNKNOWN
NA
One-year Clinical Evaluation of Bulk-fill Versus Conventional Incremental Posterior Restoration by FDI Criteria
NCT02891967
RECRUITING
NA
18-Month Clinical Evaluation of Self-Adhesive Flowable Giomer Compared to Conventional Flowable Giomer in Conservative Occlusal Restorations
NCT06956651
NOT_YET_RECRUITING
NA
Retention Rate of Hydroxyapatite Nano-Fiber Reinforced Flowable Composite Versus Conventional
NCT03264105
UNKNOWN
NA
Clinical Evaluation of Different Bulk-fill Composite Restorations on Posterior Teeth
NCT06226389
ACTIVE_NOT_RECRUITING
NA